Kazia Therapeutics (KZIA) Non-Current Deferred Tax Liability (2017 - 2025)

Kazia Therapeutics' Non-Current Deferred Tax Liability history spans 6 years, with the latest figure at $174197.8 for Q2 2025.

  • For Q2 2025, Non-Current Deferred Tax Liability fell 86.9% year-over-year to $174197.8; the TTM value through Jun 2025 reached $174197.8, down 86.9%, while the annual FY2025 figure was $174197.8, 86.9% down from the prior year.
  • Non-Current Deferred Tax Liability reached $174197.8 in Q2 2025 per KZIA's latest filing, down from $1.3 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $1.8 million in Q2 2022 to a low of $174197.8 in Q2 2025.
  • Average Non-Current Deferred Tax Liability over 4 years is $1.2 million, with a median of $1.4 million recorded in 2023.
  • Peak YoY movement for Non-Current Deferred Tax Liability: decreased 13.07% in 2024, then plummeted 86.9% in 2025.
  • A 4-year view of Non-Current Deferred Tax Liability shows it stood at $1.8 million in 2022, then dropped by 16.57% to $1.5 million in 2023, then fell by 13.07% to $1.3 million in 2024, then tumbled by 86.9% to $174197.8 in 2025.
  • Per Business Quant, the three most recent readings for KZIA's Non-Current Deferred Tax Liability are $174197.8 (Q2 2025), $1.3 million (Q2 2024), and $1.5 million (Q2 2023).